Tubea | Treatment | Fluorochrome antibody |
---|---|---|
1 | Without exposure | Negative control |
2 | Cisplatin 100 µg/(10 µL) | Positive control |
3 | Without exposure | CD34 APC, CD40 PE, CD154 FITC |
4 | Without exposure | CD34 APC, Caspase-3 FITC |
5 | rhTNFα 48 ng | CD34 APC, Caspase-3 FITC |
6 | Without exposure | CD33 PE, Caspase-3 FITC |
7 | rhTNFα 48 ng/well | CD34 APC, CD33 PE, Caspase-3 FITC |
8 | Without exposure | CD41 PE, Caspase-3 FITC |
9 | rhTNFα 48 ng/well | CD34 APC, CD41a PE, Caspase-3 FITC |
10 | Without exposure | CD73 PE, Caspase-3 FITC |
11 | rhTNFα 48 ng/well | CD34 APC, CD73 PE, Caspase-3 FITC |